News & events.

Our news.

Filter by Category
Filter by Year
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
News
August 3, 2022
2022

AbCellera and Atlas Venture Collaborate to Empower the Development of Impactful Medicines for Patients

Read article
News
July 27, 2022
2022

Versant Ventures Collaborates with AbCellera to Accelerate Drug Development for its Portfolio of Biotech Companies

Read article
News
July 12, 2022
2022

AbCellera to Report Second Quarter 2022 Financial Results on August 9, 2022

Read article
News
June 30, 2022
2022

Lilly to Supply an Additional 150,000 Doses of AbCellera-Discovered Antibody, Bebtelovimab, to the U.S. Government in Ongoing Effort to Provide COVID-19 Treatment Options

Read article
Event
May 25, 2022
2022

MaRS Impact Health 2022

Read article
Event
May 24, 2022
2022

The Data Effect: How to Build a Digital Society 2022

Read article
Event
May 18, 2022
2022

BIO International Convention 2022

Read article
News
May 3, 2022
2022

AbCellera and Empirico Expand Strategic Multi-Target Antibody Discovery Collaboration

Read article
News
April 26, 2022
2022

AbCellera to Present at the 2022 Bloom Burton & Co. Healthcare Investor Conference on May 2, 2022

Read article
News
April 12, 2022
2022

AbCellera to Report First Quarter 2022 Financial Results on May 10, 2022

Read article